---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-021345"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2025-03-07T23:59:59+00:00"
generated_at: "2026-05-25T03:35:43.589098+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma receives US patent for stress-induced affective disorder prophylactics

## Summary
- USPTO granted Patent No. 12,239,614 for exclusively licensed Columbia University technology.
- Patent titled 'Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females'.
- Patent covers prophylactic treatment for stress-induced affective disorders specifically in females.
- License is exclusive from Columbia University; patent application originally filed as 17/954864.

## SEC filing metadata
- accession: 0001213900-25-021345
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2025-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390025021345/0001213900-25-021345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390025021345/ea0233504-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-021345
- JSON: https://secwatch.observer/filing/0001213900-25-021345.json
- Plain text: https://secwatch.observer/filing/0001213900-25-021345.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.